| Literature DB >> 32642067 |
Yutaka Takahara1, Yoko Ishige1, Ikuyo Shionoya1, Yuki Fujimoto1, Taku Oikawa1, Shiro Mizuno1.
Abstract
We herein report a case of lung cancer with recurrent superior vena cava (SVC) syndrome, which was treated with additional stent placement. Our report suggests the possibility that additional SVC stent placement is an option for treatment of tumour ingrowth, even in patients with poor performance status.Entities:
Keywords: Additional stent; SVC syndrome; lung cancer; tumour ingrowth
Year: 2020 PMID: 32642067 PMCID: PMC7330812 DOI: 10.1002/rcr2.619
Source DB: PubMed Journal: Respirol Case Rep ISSN: 2051-3380
Figure 1Contrast‐enhanced computed tomography (CT) images of the thorax in the axial (A) and coronal (B) planes. Chest CT showed a mediastinal mass and severe stenosis of the superior vena cava. The tumour invaded the mediastinum.
Figure 2Contrast‐enhanced computed tomography (CT) images of the thorax in the axial (A) and coronal (B) planes. Chest CT showed proximal obstruction of the initial superior vena cava (SVC) stent by tumour ingrowth (arrows).
Figure 3An angiograph (A) and computed tomography (CT) scan (B) of the post‐stenting superior vena cava (SVC). (A) An additional SVC stent was placed and post‐stenting venogram showed flow improvement in the SVC. (B) The distal end of the additional stent was located just proximal to the right atrium.